Dictyocaulus viviparus: Bovine Lungworm (Husk) and Verminous Pneumonia, A Clinical and Diagnostic Guide

Etiology and Taxonomy

Dictyocaulus viviparus is a parasitic nematode belonging to the family Dictyocaulidae within the order Strongylida. It is the primary causative agent of parasitic bronchitis (verminous pneumonia) in cattle, a condition commonly referred to as husk. The adult worms reside in the trachea and bronchi of the host, where they induce a potent inflammatory response. The genus Dictyocaulus also includes D. filaria (infecting sheep and goats) and D. arnfieldi (infecting equids), though cross-species transmission is limited [1, 2, 35]. Recent molecular characterization of isolates from North American bison (Bison bison) has confirmed host-specific genetic differentiation, and analyses of specimens from European bison (Bison bonasus) have suggested the existence of a distinct subspecies [1, 2].

The D. viviparus genome has been fully sequenced and annotated, providing insights into its biology and potential intervention targets. The genome (approximately 180 Mb) contains a complement of genes involved in cuticle synthesis, neurotransmitter function, and immune evasion [32]. Notably, the major sperm protein (MSP) and paramyosin have been characterized as immunodominant antigens and are the basis for serological diagnostic assays and experimental vaccine candidates [3, 33, 37]. The parasite also expresses an asparaginyl peptidase (legumain-1) that has been evaluated as a potential vaccine target due to its role in larval migration and host tissue degradation [24].

Epidemiology and Distribution

D. viviparus is a globally distributed pathogen of cattle, with a high prevalence in temperate regions where grazing systems predominate. In Europe, retrospective analyses of disease registries have demonstrated that the incidence of husk exhibits spatiotemporal variation correlated with climate patterns [21, 40]. A modeling study using climate variables (temperature and rainfall) has been developed to predict peak pasture infectivity, which typically occurs from mid-summer to early autumn [4]. In Iran, the prevalence of lungworm infections in pastoral ruminants remains a significant concern, with D. viviparus being the dominant species in cattle [5]. Retrospective epidemiological surveys from Brazil have documented D. viviparus over four decades, with prevalence rates varying by region and management system [6]. A study of beef cattle in northeastern Brazil using larvoscopic techniques confirmed ongoing transmission in that region [7].

Environmental factors strongly influence the epidemiology of the parasite. The free-living stages (egg, L1, L2, and L3 larvae) require adequate moisture and moderate temperatures for development. Pasture rewetting, a conservation practice in Europe, showed no long-term impact on infection rates in cattle and sheep, although the study design may not have captured acute transmission events [8]. A large-scale study in Germany found that bulk tank milk (BTM) seropositivity was correlated with meteorological variables, particularly high precipitation and moderate temperatures in the preceding months [9]. In Great Britain, a 40-year spatiotemporal analysis indicated that disease reports have increased in some western regions, possibly linked to changes in rainfall patterns [21].

Seroprevalence surveys in German dairy herds using an MSP-based ELISA estimated that over 50% of herds had been exposed to D. viviparus, with herd-level management factors such as grazing of young stock and the use of anthelmintic treatment protocols being significant risk factors [10, 40]. In Dutch dairy herds, the association between BTM antibody levels and farmer-reported lungworm outbreaks has been validated, confirming BTM ELISA as a reliable herd-level surveillance tool [11, 28]. A scoping review of nonbacterial pathogen testing in BTM identified D. viviparus as one of the key targets for which serological testing is well-established [12].

Pathogenesis and Pathology

Life Cycle and Host Invasion

Adult D. viviparus are slender, white nematodes measuring 3 to 8 cm in length. They reside in the lumen of the trachea and larger bronchi. The female worms are ovoviviparous, releasing eggs that hatch almost immediately into first-stage larvae (L1). These L1 larvae are coughed up, swallowed, and excreted in the feces. On pasture, L1 develop through two molts to the infective third-stage (L3) under favorable climatic conditions (optimal temperature 10 to 20 degrees Celsius, with high humidity). The development time from egg to L3 is approximately 7 to 10 days under optimal conditions but can extend to several weeks in cooler weather [4].

Following ingestion of L3 by a grazing animal, the larvae penetrate the intestinal wall and migrate via the lymphatics to the mesenteric lymph nodes. Within the lymph nodes, larvae molt to the fourth stage (L4) and then travel via the lymphatic and venous circulation to the right heart and then to the pulmonary capillaries. Larvae break out of the capillaries into the alveoli and migrate into the bronchioles and bronchi, where they undergo the final molt to adults. The prepatent period is approximately 21 to 28 days.

Mechanisms of Pulmonary Pathology

The pathogenesis of verminous pneumonia is mediated by both mechanical damage and an intense host immune response. As larvae migrate through the pulmonary parenchyma, they cause focal hemorrhage, edema, and infiltration of eosinophils, neutrophils, and macrophages. This early exudative phase corresponds to the onset of clinical respiratory signs.

As adults develop in the airways, they elicit a proliferative inflammatory response characterized by goblet cell hyperplasia, mucous hypersecretion, and hypertrophy of bronchial smooth muscle. The presence of large numbers of worms, mucus, and cellular debris can lead to bronchial obstruction, atelectasis, and secondary bacterial pneumonia. The clinical condition known as husk refers to the characteristic paroxysmal coughing that occurs as the animal attempts to expel the worms and mucus.

Oxidative stress contributes significantly to the pathology. Infected dairy cows have been shown to exhibit increased serum levels of reactive oxygen species and decreased antioxidant capacity, correlating with parasite burden and clinical severity [29]. Biochemical alterations, including changes in total protein, albumin, and globulin fractions, have been documented in infected calves [31].

In chronic or recurrent infections, the immune response can lead to the formation of granulomatous lesions and fibrosis around trapped larvae and eggs in the lung parenchyma. These lesions can persist for months after the infection has cleared. The host mounts a strong humoral immune response, primarily against MSP, paramyosin, and other excretory-secretory antigens. The development of immunity occurs after primary exposure but is not sterilizing. Reinfections typically result in a lower worm burden and reduced clinical signs, a phenomenon known as "self-cure." However, immunity wanes over time, particularly in adult animals that have not been exposed recently [23, 27].

Clinical Signs

The clinical presentation of D. viviparus infection is highly dependent on the worm burden and the immune status of the host. It is classically divided into three phases.

Stage 1: Penetration and Migration Phase (Days 1 to 7 Post Infection)

This phase coincides with the arrival of L4 and L5 larvae in the lungs. Clinical signs may be mild or absent in light infections. In heavy infections, the animal may exhibit pyrexia (up to 40 degrees Celsius), tachypnea, and a frequent, dry cough. This stage is often transient.

Stage 2: Patent Phase (Days 21 to 60 Post Infection)

As adult worms develop and eggs are produced, the clinical signs become more pronounced. The cough becomes more frequent and paroxysmal, often described as a "husky" cough. Respiratory rate increases significantly, and dyspnea is evident, particularly on exertion. Nasal discharge (mucoid or mucopurulent) may be present. Affected animals typically show reduced feed intake, weight loss, and decreased milk production. Severe cases may present with open-mouth breathing and extended head and neck (orthopneic positioning). In acute outbreaks, a high number of animals in a group may be affected within a short period.

Stage 3: Chronic Phase (After 60 Days)

In animals that survive the acute phase, the disease may progress to a chronic debilitating condition. Persistent coughing, exercise intolerance, and poor body condition are common. Secondary bacterial pneumonia is a frequent complication, as the damaged airways are colonized by opportunistic bacteria such as Pasteurella multocida and Histophilus somni. Milk yield losses can be substantial; a study of German dairy cows found that patent D. viviparus (re)infections resulted in significant reductions in individual milk yield and alterations in milk quality parameters, including somatic cell count and fat content [23]. Helminth co-infections, including lungworm and gastrointestinal nematodes, were not found to have an additive detrimental effect on milk yield compared to mono-infections in a separate German study [13].

Subclinical Infection

Many infections, particularly in adult animals with partial immunity, remain subclinical. These animals may not display overt respiratory signs but can suffer from reduced productivity. BTM seropositivity has been consistently associated with lower milk production at the herd level, indicating a significant economic impact from subclinical disease [14, 28, 34]. A retrospective analysis of 20 outbreaks in Argentina highlighted that clinical disease is often first noted in heifers and young stock, but subclinical infections in adults can perpetuate the transmission cycle [15].

Diagnosis

A definitive diagnosis of D. viviparus infection relies on a combination of clinical suspicion, epidemiological history, parasitological examination, serological testing, and molecular detection.

Clinical and Epidemiological Assessment

A history of grazing (especially in first-season grazing animals) coupled with an acute onset of coughing and dyspnea in multiple animals is highly suggestive. The absence of significant pyrexia early in the course of the disease helps differentiate husk from bacterial pneumonias or viral infections such as bovine respiratory syncytial virus (BRSV) or Mycoplasma bovis infection.

Parasitological Methods

The gold standard for confirmation of patent infection is the detection of L1 larvae in fecal samples. The Baermann technique is preferred for its higher sensitivity. In this method, a sample of fresh feces (10 to 20 g) is suspended in a funnel filled with lukewarm water. After 12 to 24 hours, the sediment is examined microscopically for motile L1 larvae. The larvae are identified by their characteristic morphology: a straight tail with a small spine-like projection (kink) and a visible buccal capsule.

Detection of L1 is specific for patent infections but has low sensitivity, particularly in early disease (prepatent period) or chronic cases. The prepatent period of 21 to 28 days means that fecal examination can be negative during the early migration phase when clinical signs are already present. Larvoscopic examination of feces remains a standard diagnostic approach in many regions [7].

Serological Methods: MSP-ELISA

Serological testing has become a cornerstone of diagnosis, particularly for subclinical and herd-level detection. The most widely used tests are ELISAs targeting the recombinant major sperm protein (rMSP) of D. viviparus. Both serum and BTM ELISAs are available.

The BTM ELISA is a powerful tool for herd-level surveillance. It detects antibodies that have been concentrated in the milk and provides a convenient, noninvasive method for monitoring dairy herds. Studies have validated the BTM MSP-ELISA for diagnosing natural (sub)clinical infections. A one-year longitudinal field study confirmed the utility of the test and provided data for cut-off adjustment [42]. The BTM ELISA has been shown to correlate with farmer-reported lungworm outbreaks and with milk yield losses [11, 28]. In Dutch herds, BTM antibody levels were significantly associated with production parameters [34]. A comparative study of serum and BTM ELISAs found that both methods were suitable for diagnosis at the herd level, but that the BTM ELISA was more practical for routine screening of dairy herds [39]. Other studies have optimized the rMSP ELISA protocol for routine diagnostic use [45]. The value of combining BTM ELISA with individual serology and faecal examination has been demonstrated for diagnosing both clinical and subclinical infections [46].

Serology is particularly useful for identifying herds with a history of exposure, even if the infection is not patent at the time of sampling. However, the kinetics of the antibody response are important to interpret. Research has demonstrated that antibody titers develop independently of the infection dose and that reinfection shortens the duration of seropositivity [27]. Therefore, a positive test indicates recent or current exposure but does not measure the current worm burden.

Molecular Diagnostics: PCR and DviLAMP

Molecular detection methods offer high sensitivity and specificity for the detection of D. viviparus DNA in fecal samples or lung tissue.

Conventional PCR and multiplex PCR assays have been developed that target the internal transcribed spacer (ITS-2) or the small subunit ribosomal RNA (SSU) gene. These assays can differentiate D. viviparus from other Dictyocaulus species in domestic and wild ruminants, which is useful for epidemiological studies [35, 38].

A significant advance in point-of-care diagnostics is the development of loop-mediated isothermal amplification (LAMP) assays. The DviLAMP assay, targeting the D. viviparus SSU gene, has been developed and validated [16]. LAMP offers several advantages over PCR: it is isothermal (requires only a heat block), rapid (results in under 60 minutes), and highly tolerant of inhibitors present in fecal samples. The DviLAMP assay demonstrated a detection limit comparable to quantitative PCR and offers the potential for on-farm diagnosis, particularly in resource-limited settings [16].

Diagnostic Pathology

Postmortem examination reveals characteristic lesions. The lungs appear heavy, edematous, and may fail to collapse. The most typical finding is the presence of large numbers of adult worms (3 to 8 cm long, white) in the major bronchi and trachea. The bronchial epithelium may be thickened, hyperemic, and covered with a frothy, blood-tinged exudate. The caudal (diaphragmatic) lung lobes are most severely affected. Histological examination shows a severe eosinophilic bronchiolitis, with epithelial desquamation, goblet cell hyperplasia, and infiltration of the lamina propria by eosinophils, plasma cells, and lymphocytes. In chronic cases, granulomatous nodules may surround degenerating larvae or eggs in the lung parenchyma.

flowchart TD
    A[Clinical Suspicion / Epidemiological Risk], > B{History of Grazing?}
    B, Yes, > C[Fecal Sample (Baermann)]
    B, No, > D[Consider Other Respiratory Pathogens]
    C, > E{L1 Larvae Detected?}
    E, Yes, > F[Confirm Patent Infection / Initiate Treatment]
    E, No, > G{Herd-Level Screening?}
    G, Yes, > H[Bulk Tank Milk MSP-ELISA]
    G, No, > I[Collect Serum for Individual MSP-ELISA]
    H, > J{BTM OD Above Cut-Off?}
    I, > J
    J, Yes, > K[High Likelihood of Herd Exposure / Subclinical Infection]
    J, No, > L[Low Likelihood of Recent Exposure]
    K, > M{Consider Molecular Confirmation}
    F, > M
    M, > N[Fecal PCR or DviLAMP LAMP]
    N, > O{Positive?}
    O, Yes, > P[Confirm Infection / Genotype if Needed]
    O, No, > Q[False Negative Baermann? Re-evaluate Clinically]
    P, > R[Implement Treatment & Control]
    Q, > R

Treatment and Anthelmintic Resistance

Control of D. viviparus has historically relied on the use of anthelmintics, particularly the macrocyclic lactones (MLs) (ivermectin, eprinomectin, moxidectin, and doramectin) and, to a lesser extent, the benzimidazoles (e.g., fenbendazole, albendazole) and imidazothiazoles (levamisole).

Efficacy of Macrocyclic Lactones

Ivermectin and moxidectin are highly effective against both adult worms and migrating larvae. Eprinomectin (in both pour-on and injectable formulations) is widely used due to its zero-milk-withdrawal status in many countries. A study evaluating the efficacy of eprinomectin extended-release injection showed excellent nematode burden control, including D. viviparus, in pastured cattle treated at turnout [41].

Documented Resistance

A growing body of evidence indicates that resistance to multiple anthelmintic classes is emerging in field populations of D. viviparus. A critical report from Scotland documented the inefficacy of ivermectin and moxidectin treatments against D. viviparus in dairy calves, using a controlled efficacy trial design [17]. In a field investigation in Brazil, researchers found a lack of efficacy of macrocyclic lactones (ivermectin, moxidectin, doramectin) as well as albendazole and levamisole against a field population of D. viviparus [18]. This is the first report describing resistance to all three major anthelmintic classes (MLs, benzimidazoles, and imidazothiazoles) in a single D. viviparus population, confirming that resistant genotypes are circulating and that alternative treatment strategies are urgently needed.

Alternative Approaches

Given the emergence of resistance, there is renewed interest in non-chemotherapeutic control options. Experimental vaccination has been explored using recombinant paramyosin and legumain-1 antigens. Vaccination with recombinant paramyosin was shown to considerably reduce worm burden and larvae shedding in experimentally challenged calves [37]. Immunization trials with recombinant MSP have also been attempted, although the resulting immune responses were not sufficient to provide full protection [3]. These vaccines are not yet commercially available.

Pasture management strategies, including rotational grazing, avoidance of heavy stocking rates, and use of clean pastures (e.g., after silage or hay crops) can reduce larval exposure. Treatment of high-risk groups (e.g., first-season grazing calves) at strategic times can help reduce pasture contamination. However, regular monitoring for anthelmintic efficacy is recommended, particularly via fecal egg count reduction tests (FECRT) adapted for D. viviparus larvae. A study on a targeted selective treatment (TST) approach in suckler beef calves demonstrated that treating only those with significantly elevated L1 counts or low weight gain was feasible, but its impact on preventing pasture contamination and clinical outbreaks requires further evaluation [36].

Control and Prevention

Control strategies integrate grazing management, strategic anthelmintic use, and vaccination (where available).

Grazing Management

Pasture larvae are susceptible to desiccation and sunlight. Grazing young stock on pasture that has not been used by cattle for the previous 12 months or that has been cut for silage can drastically reduce exposure. Heavy pasture contamination can persist for months under favorable conditions. A single mass-treatment before turnout has been shown to be insufficient to eradicate the parasite from dairy farms, as contaminate pastures from residual larvae or from carrier animals can reintroduce infection [44].

Herd Immunity

The development of herd immunity is an important factor. Heifers that are exposed to low levels of challenge during their first grazing season often develop a protective immunity. However, this immunity wanes. The practice of introducing susceptible heifers (e.g., from indoor-rearing systems) into a high-challenge environment can result in severe clinical outbreaks.

Monitoring

Regular herd-level monitoring via BTM ELISA provides an early warning of increased parasite transmission. Herds that seroconvert should be considered at risk, and decisions regarding anthelmintic treatment should be made promptly. The economic burden of D. viviparus infection is substantial. A study estimated that the economic loss due to parasitic helminth infections, including lungworm, in European ruminant livestock is significant, driven primarily by production losses (milk yield and growth) and the cost of treatment [20].

Future Directions

The emergence of multi-drug resistant D. viviparus populations [18, 17] necessitates a paradigm shift in control. Future research should focus on the following areas:

1. Resistance Mechanisms: Understanding the molecular basis of ML, benzimidazole, and levamisole resistance in D. viviparus is critical for developing rapid diagnostic tests (e.g., allele-specific PCR assays for resistance markers).
2. Vaccine Development: Continued optimization of recombinant vaccines, potentially combining multiple antigens (e.g., paramyosin, legumain-1, MSP), is a high priority.
3. Decision Support Tools: Integration of climate-based predictive models [4] with serological monitoring [9, 11] could allow for targeted, risk-based anthelmintic use, reducing selection pressure for resistance.
4. Genetic Selection: Genomic studies in cattle have started to identify genetic markers associated with endoparasite resistance, including resistance to D. viviparus [22, 25]. Breeding for host resistance could offer a long-term, sustainable control strategy.

References

[1] A Danks H, Sobotyk C, N Saleh M, et al. Opening a can of lungworms: Molecular characterization of Dictyocaulus (Nematoda: Dictyocaulidae) infecting North American bison (Bison bison). Int J Parasitol Parasites Wildl. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35572037/

[2] Pyziel AM, Laskowski Z, Dolka I, et al. Large lungworms (Nematoda: Dictyocaulidae) recovered from the European bison may represent a new nematode subspecies. Int J Parasitol Parasites Wildl. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33209582/

[3] Springer A, von Holtum C, von Samson-Himmelstjerna G, et al. Immunization Trials with Recombinant Major Sperm Protein of the Bovine Lungworm Dictyocaulus viviparus. Pathogens. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35056003/

[4] McCarthy C, Vineer HR, Morgan ER, et al. Predicting the unpredictable? A climate-based model of the timing of peak pasture infectivity for Dictyocaulus viviparus. Vet Parasitol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35921740/

[5] Zafari S, Mohtasebi S, Sazmand A, et al. The Prevalence and Control of Lungworms of Pastoral Ruminants in Iran. Pathogens. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36558726/

[6] de Macedo LO, Lima TARF, Verocai GG, et al. Lungworms in ruminants from Brazil: A retrospective epidemiological study over four decades. Vet Parasitol Reg Stud Reports. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34879956/

[7] Macedo LO, Ubirajara Filho CRC, Brito RS, et al. Larvoscopic study on Dictyocaulus sp. in the faeces of beef cattle in northeastern Brazil. Rev Bras Parasitol Vet. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36000610/

[8] May K, Raue K, Blazejak K, et al. Pasture rewetting in the context of nature conservation shows no long-term impact on endoparasite infections in sheep and cattle. Parasit Vectors. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35062999/

[9] Vanhecke M, Charlier J, Hamdi R, et al. Dictyocaulus viviparus bulk tank milk seropositivity is correlated with meteorological variables. Int J Parasitol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35917951/

[10] Springer A, Jordan D, Kirse A, et al. Seroprevalence of Major Pasture-Borne Parasitoses (Gastrointestinal Nematodes, Liver Flukes and Lungworms) in German Dairy Cattle Herds, Association with Management Factors and Impact on Production Parameters. Animals (Basel). 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34359205/

[11] Vanhecke M, Charlier J, Strube C, et al. Association between Dictyocaulus viviparus bulk tank milk

[12] Nobrega DB, French JE, Kelton DF. A scoping review of the testing of bulk tank milk to detect nonbacterial pathogens or herd exposure to nonbacterial pathogens in dairy cattle. J Dairy Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37291033/

[13] May K, Hecker AS, König S, et al. Helminth co-infections have no additive detrimental impact on milk yield and milk quality compared to mono-infections in German dairy cows. Parasit Vectors. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39300583/

[14] Vanhecke M, Charlier J, Strube C, et al. Risk factors for lungworm-associated milk yield losses in grazing dairy cattle. Vet Parasitol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33752038/

[15] Ovelar MF, Cantón GJ, Odriozola E, et al. Dictyocaulosis in cattle: Retrospective analysis of 20 outbreaks in Central Argentina. Vet Parasitol Reg Stud Reports. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39326962/

[16] Nak-On S, Campbell P, Shalaby MM, et al. Development of a loop-mediated isothermal amplification detection assay for Dictyocaulus viviparus (Bloch, 1782) lungworm: DviLAMP. Front Vet Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39430381/

[17] Campbell P, Forbes A, McIntyre J, et al. Inefficacy of ivermectin and moxidectin treatments against Dictyocaulus viviparus in dairy calves. Vet Rec. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38845174/

[18] Coelho ML, Borges DGL, Sobota IP, et al. Lack of efficacy of macrocyclic lactones, albendazole, and levamisole against a field population of Dictyocaulus viviparus in cattle. Vet Parasitol Reg Stud Reports. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40967699/

[19] Constancis C, Chartier C, Leligois M, et al. Gastrointestinal nematode and lungworm infections in organic dairy calves reared with nurse cows during their first grazing season in western France. Vet Parasitol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35078069/